Skip to content

APOTHEEK KEYMOLEN

Active Private limited companyfounded 1995active for 30 yearsHooigaardestraat 1, 1800 VilvoordeKBO/BCE: BE 0456.560.291

Lifetime

20 annual accounts with figures on one time axis, 30 filings since 1996
peak of €283,013 in 2025
€283,013▲ 0.7%
lowest -€21,957 in 2017
€128,654▼ 9.9%
peak of €609,586 in 2024
€440,440▼ 27.7%
€480,478▲ 48.7%
peak of 1.3 FTE in 2016
0.9 FTEunchanged
Board1 name since 2014
1 director
Documentsfilings and deeds
17-06-202644 days before the deadline
2025abbreviated format
Dividend €297,800Equity from €609,586 to €440,440Debts from €323,121 to €480,478Investments €16,596

Key points

from the 2025 annual accounts

Equity

€440,440 ▼ 27.7%
609,5862024+128,654Profit-297,800Dividend440,4402025

APOTHEEK KEYMOLEN paid out €297,800 in dividends. That is 231% of the 2025 profit.

Turnover

≈ €980,000 estimated

The abbreviated format states no turnover.

Debts

€480,478 ▲ 48.7%
Other debts
+150,782
Suppliers
+6,772
Taxes and wages
+2,025
The rest
-2,222

Debts rose by €157,356 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Investments

€16,596 1.8 times depreciation
2022202320242025

Green is investment, beige is depreciation. Machinery stands 116.4% higher than in 2024.

Liquidity

1.82 was 2.82 in 2024

Short-term debts rose from €310,267 to €469,846.

Filings

30 annual accounts since 1996
AprilJune31 JulyOctober200020102020

Six of the last ten came late. The 2020 accounts came in latest, 24 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as APOTHEEK KEYMOLEN has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for APOTHEEK KEYMOLEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-10-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0456560291
changes role from manager to director acts as permanent representative · General meeting of 06-01-2022 · Gazette deed
New manager appointed, resigned · General meeting of 19-01-2015 · Gazette deed
First establishment Hooigaardestraat 1, Vilvoorde
All 41 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK KEYMOLEN Vilvoorde €0.9m €283,013 47.8% 0.9
YOKRIPHAR Tienen €0.9m €292,311 32.6% 1
APOTHEEK MATTELAER Kortrijk €1.0m €286,517 53.8% 1
APOTHEEK BEKKEVOORT Bekkevoort €1.1m €318,877 15.9% 1
APOTHEEK VANACKERE Kortrijk €0.9m €250,945 55.1% 1
FARMA WAELPUT Beveren-Kruibeke-Zwijndrecht €1.0m €258,723 82.3% 0.9
MEDIFAR Meerhout €0.9m €247,744 94.3% 0.7

These companies have the same main activity as APOTHEEK KEYMOLEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €920,000 and €1.1m, founded between 1992 and 2001.

Official details

Source: KBO
Status
Active since 04-12-1995Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.074.320.5511800 Vilvoorde, since 15-12-1995
Financial year end
31 December
Peppol
Reachable since 08-01-2026
Company details

Annual accounts 2025

€920,917▼ 1.3%
Employeeson 31-12-2025
1=
Filing
Filed on 17-06-2026, 44 days before the end of the filing period
Financials

Insights on APOTHEEK KEYMOLEN

APOTHEEK KEYMOLEN files the abbreviated format. That format states no turnover. The gross margin rose from €117,511 in 2006 to €283,013 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK KEYMOLEN

What is the company number of APOTHEEK KEYMOLEN?
The company number of APOTHEEK KEYMOLEN is 0456.560.291. The VAT number is the same number with BE in front: BE 0456.560.291.
Where is APOTHEEK KEYMOLEN based?
The registered office is at Hooigaardestraat 1, 1800 Vilvoorde.Company details
What does APOTHEEK KEYMOLEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK KEYMOLEN?
APOTHEEK KEYMOLEN is a private limited company (BV).
When was APOTHEEK KEYMOLEN founded?
APOTHEEK KEYMOLEN was founded on 04-12-1995.
Is APOTHEEK KEYMOLEN still active?
Yes, APOTHEEK KEYMOLEN is an active enterprise in the KBO register.
How many employees does APOTHEEK KEYMOLEN have?
APOTHEEK KEYMOLEN had an average of 0.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK KEYMOLEN fall under?
In its 2025 annual accounts, APOTHEEK KEYMOLEN states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK KEYMOLEN?
The turnover in financial year 2025 is about €980,000. This figure is estimated from the gross margin of €283,013 and 42 comparable companies (NACE 477). It probably lies between €770,000 and €1.4m.
Is APOTHEEK KEYMOLEN profitable?
In financial year 2025, APOTHEEK KEYMOLEN made a profit of €128,654.
Where can I find the annual accounts of APOTHEEK KEYMOLEN?
APOTHEEK KEYMOLEN filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK KEYMOLEN due?
APOTHEEK KEYMOLEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.